Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2020-2025

Publisher Name :
Date: 15-Sep-2020
No. of pages: 138

According to this study, over the next five years the Neuromodulation Devices and Implantable Infusion Pumps market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neuromodulation Devices and Implantable Infusion Pumps business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Neuromodulation Devices and Implantable Infusion Pumps, covering the supply chain analysis, impact assessment to the Neuromodulation Devices and Implantable Infusion Pumps market size growth rate in several scenarios, and the measures to be undertaken by Neuromodulation Devices and Implantable Infusion Pumps companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Spinal Cord Stimulation

- Deep Brain Stimulation

- Sacral Nerve Stimulation

- Vagal Nerve Stimulation

- Gastric Stimulation

- Transcranial magnetic Stimulation

- Transcutaneous Electrical Stimulation

- Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Parkinson's disease

- Epilepsy

- Pain

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Medtronic

- Greatbatch Medical

- Boston Scientific Corporation

- Synapse Biomedical

- Nevro Corporation

- Abbott

- Autonomic Technologies

- Neuropace

- Avery Biomedical

- Cyberonics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments.

- Focuses on the key global Neuromodulation Devices and Implantable Infusion Pumps manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Neuromodulation Devices and Implantable Infusion Pumps with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2025
2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2015-2020)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2015-2020)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value and Market Share by Type (2015-2020)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2015-2020)

3 Global Neuromodulation Devices and Implantable Infusion Pumps by Company
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2018-2020)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2018-2020)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2018-2020)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2018-2020)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Neuromodulation Devices and Implantable Infusion Pumps by Regions
4.1 Neuromodulation Devices and Implantable Infusion Pumps by Regions
4.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.5 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth

5 Americas
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions (2015-2020)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Value by Regions (2015-2020)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Countries
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
10.3 Neuromodulation Devices and Implantable Infusion Pumps Customer

11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast (2021-2025)
11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions
11.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions (2021-2025)
11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
11.8 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application

12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Information
12.1.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Greatbatch Medical
12.2.1 Company Information
12.2.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.2.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Greatbatch Medical Latest Developments
12.3 Boston Scientific Corporation
12.3.1 Company Information
12.3.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.3.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boston Scientific Corporation Latest Developments
12.4 Synapse Biomedical
12.4.1 Company Information
12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Synapse Biomedical Latest Developments
12.5 Nevro Corporation
12.5.1 Company Information
12.5.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Nevro Corporation Latest Developments
12.6 Abbott
12.6.1 Company Information
12.6.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.6.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Abbott Latest Developments
12.7 Autonomic Technologies
12.7.1 Company Information
12.7.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.7.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Autonomic Technologies Latest Developments
12.8 Neuropace
12.8.1 Company Information
12.8.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.8.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Neuropace Latest Developments
12.9 Avery Biomedical
12.9.1 Company Information
12.9.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Avery Biomedical Latest Developments
12.10 Cyberonics
12.10.1 Company Information
12.10.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.10.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Cyberonics Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Spinal Cord Stimulation
Table 5. Major Players of Deep Brain Stimulation
Table 6. Major Players of Sacral Nerve Stimulation
Table 7. Major Players of Vagal Nerve Stimulation
Table 8. Major Players of Gastric Stimulation
Table 9. Major Players of Transcranial magnetic Stimulation
Table 10. Major Players of Transcutaneous Electrical Stimulation
Table 11. Major Players of Other
Table 12. Global Consumption Sales by Type (2015-2020)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2015-2020) ($ million)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Type (2015-2020) ($ Millions)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2015-2020)
Table 17. Global Consumption Sales by Application (2015-2020)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Value by Application (2015-2020)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Application (2015-2020)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2015-2020)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2017-2019) (K Units)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2017-2019)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2017-2019) ($ Millions)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2017-2019)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2017-2019)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Sales Area by Manufacturers
Table 28. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 29. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions 2015-2020 (K Units)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Regions 2015-2020
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Value by Regions 2015-2020 ($ Millions)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions 2015-2020
Table 34. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 35. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 36. Americas Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020) ($ Millions)
Table 37. Americas Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries (2015-2020)
Table 38. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 39. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 40. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 42. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 43. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 44. APAC Neuromodulation Devices and Implantable Infusion Pumps Value by Regions (2015-2020) ($ Millions)
Table 45. APAC Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions (2015-2020)
Table 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 48. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020) ($ Millions)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries (2015-2020)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 57. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 58. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 59. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020) ($ Millions)
Table 61. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 63. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 64. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 65. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 66. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 67. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Countries (2021-2025) (K Units)
Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Forecast by Regions
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Countries (2021-2025) ($ Millions)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share Forecast by Regions
Table 72. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Type (2021-2025) (K Units)
Table 73. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Forecast by Type (2021-2025)
Table 74. Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Type (2021-2025) ($ Millions)
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share Forecast by Type (2021-2025)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Application (2021-2025) (K Units)
Table 77. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Forecast by Application (2021-2025)
Table 78. Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Application (2021-2025) ($ Millions)
Table 79. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share Forecast by Application (2021-2025)
Table 80. Medtronic Product Offered
Table 81. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. Medtronic Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 85. Greatbatch Medical Product Offered
Table 86. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Greatbatch Medical Main Business
Table 88. Greatbatch Medical Latest Developments
Table 89. Greatbatch Medical Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Corporation Product Offered
Table 91. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Boston Scientific Corporation Main Business
Table 93. Boston Scientific Corporation Latest Developments
Table 94. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. Synapse Biomedical Product Offered
Table 96. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Synapse Biomedical Main Business
Table 98. Synapse Biomedical Latest Developments
Table 99. Synapse Biomedical Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Nevro Corporation Product Offered
Table 101. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Nevro Corporation Main Business
Table 103. Nevro Corporation Latest Developments
Table 104. Nevro Corporation Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Abbott Product Offered
Table 106. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 107. Abbott Main Business
Table 108. Abbott Latest Developments
Table 109. Abbott Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. Autonomic Technologies Product Offered
Table 111. Autonomic Technologies Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 112. Autonomic Technologies Main Business
Table 113. Autonomic Technologies Latest Developments
Table 114. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. Neuropace Product Offered
Table 116. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Neuropace Main Business
Table 118. Neuropace Latest Developments
Table 119. Neuropace Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Avery Biomedical Product Offered
Table 121. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Avery Biomedical Main Business
Table 123. Avery Biomedical Latest Developments
Table 124. Avery Biomedical Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. Cyberonics Product Offered
Table 126. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Cyberonics Main Business
Table 128. Cyberonics Latest Developments
Table 129. Cyberonics Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Spinal Cord Stimulation
Figure 7. Product Picture of Deep Brain Stimulation
Figure 8. Product Picture of Sacral Nerve Stimulation
Figure 9. Product Picture of Vagal Nerve Stimulation
Figure 10. Product Picture of Gastric Stimulation
Figure 11. Product Picture of Transcranial magnetic Stimulation
Figure 12. Product Picture of Transcutaneous Electrical Stimulation
Figure 13. Product Picture of Other
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Figure 15. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Type (2015-2020)
Figure 16. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's disease
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's disease (2015-2020) (K Units)
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's disease (2015-2020) ($ Millions)
Figure 19. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2015-2020) (K Units)
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2015-2020) ($ Millions)
Figure 22. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Pain
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2015-2020) (K Units)
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2015-2020) ($ Millions)
Figure 25. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2015-2020) (K Units)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2015-2020) ($ Millions)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Application (2015-2020)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2017
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2017
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2019
Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company in 2019
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Regions 2015-2020
Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions 2015-2020
Figure 37. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 38. Americas Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 39. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 40. APAC Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 41. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 42. Europe Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 43. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 44. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 45. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries in 2019
Figure 46. Americas Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries in 2019
Figure 47. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type in 2019
Figure 48. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application in 2019
Figure 49. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 50. United States Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 51. Canada Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 52. Canada Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 53. Mexico Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 54. Mexico Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 55. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries in 2019
Figure 56. APAC Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions in 2019
Figure 57. APAC Neuromodulat
  • (COVID-19 Version) Global Cranial Stabilization System Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Cranial Stabilization System market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cranial Stabilization System industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cranial St......
  • (COVID-19 Version) Global Crohn s Disease Drug Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 100
    Summary The report forecast global Crohn s Disease Drug market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Crohn s Disease Drug industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Crohn s Disease Drug By ge......
  • (COVID-19 Version) Global CT Scanner and C-Arm Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 101
    Summary The report forecast global CT Scanner and C-Arm market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of CT Scanner and C-Arm industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading CT Scanner and C-Arm By ge......
  • (COVID-19 Version) Global Cupping Devices Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Cupping Devices market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cupping Devices industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cupping Devices By geography. The re......
  • (COVID-19 Version) Global Cyclin Dependent Kinase 6 Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 105
    Summary The report forecast global Cyclin Dependent Kinase 6 market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cyclin Dependent Kinase 6 industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cyclin Dependent......
  • (COVID-19 Version) Global Cyclin Dependent Kinase 7 Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 92
    Summary The report forecast global Cyclin Dependent Kinase 7 market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cyclin Dependent Kinase 7 industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cyclin Dependent......
  • (COVID-19 Version) Global Cyclin Dependent Kinase 9 Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 101
    Summary The report forecast global Cyclin Dependent Kinase 9 market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cyclin Dependent Kinase 9 industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cyclin Dependent......
  • (COVID-19 Version) Global Cystometry Catheters Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Cystometry Catheters market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cystometry Catheters industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Cystometry Catheters By ge......
  • (COVID-19 Version) Global Cytochrome P450 11B2 Mitochondrial Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Sep-2020        Price: US 3000 Onwards        Pages: 110
    Summary The report forecast global Cytochrome P450 11B2 Mitochondrial market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Cytochrome P450 11B2 Mitochondrial industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leadin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs